Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Unresectable or Metastatic Solid Malignancy × pertuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 32 Neoplasms 5 HER2-positive Breast Cancer 4 Neoplasm Metastasis 3 Multiple Myeloma 3 Endometrial Neoplasms 3 Stomach Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 HER2-positive Early Breast Cancer 2 Colonic Neoplasms 2 Brain Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Salivary Gland Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Patient Preference 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Meningeal Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡